Glycogen storage disease IC is a rare inherited condition that affects how the body releases stored sugar, so low blood sugar can happen between feeds or meals. It usually begins in infancy or early childhood and is lifelong, and common features can include an enlarged liver, poor growth, and high levels of fats and uric acid in the blood. For some, the first sign may be a small change they brush off at first, such as shakiness, sweating, or unusual sleepiness when they have not eaten for a while. Glycogen storage disease IC is treated mainly with careful meal planning, frequent carbohydrates, and uncooked cornstarch, and some people also need treatment for related problems such as gout or high blood fats. The outlook for people with glycogen storage disease IC varies, but serious complications can happen without treatment, so early diagnosis and regular specialist care are important.
How many people live with Glycogen storage disease ic?
Using the often-cited overall rate for glycogen storage disease type I of about 1 in 100,000 people, that suggests roughly 80,000 people worldwide (MedlinePlus Genetics, 2024; UN World Population Prospects, 2024) and about 3,400 people in the United States (MedlinePlus Genetics, 2024; U.S. Census Bureau, 2024). For glycogen storage disease Ic specifically, separate worldwide and U.S. numbers are not reliably reported because this older subtype name is now usually counted together with type Ib, so any Ic total would be only a rough estimate rather than a direct count (GeneReviews, 2023).
Overview
Glycogen storage disease icSymptoms
Glycogen storage disease IC often causes low blood sugar, a swollen belly from an enlarged liver, and poor growth. Many living with glycogen storage disease IC also have high blood fats and muscle weakness.
Outlook and prognosis
With glycogen storage disease IC, outlook is good when low blood sugar is prevented and liver, kidney, and growth problems are monitored closely. Many living with glycogen storage disease IC need lifelong diet treatment and follow-up, but can do well.
Causes and risk factors
Glycogen storage disease Ic is caused by an inherited gene change, usually passed down when both parents carry one nonworking copy. Family history raises the chance, while lifestyle and environment do not cause it, though they can affect complications.
Genetic influences
Genetics are central to Glycogen storage disease IC, which is caused by inherited changes in a gene involved in breaking down glycogen. The exact variant can help confirm the diagnosis, guide family testing, and sometimes explain differences in severity.
Diagnosis
Glycogen storage disease IC is usually diagnosed from clinical features and lab findings, then confirmed with genetic tests. In some cases, a liver biopsy may help support the diagnosis of Glycogen storage disease IC.
Treatment and drugs
Treatment for glycogen storage disease Ic focuses on steady blood sugar, often with frequent meals, overnight feeding, and uncooked cornstarch. Many living with glycogen storage disease Ic also need treatment for uric acid, fats, and careful liver and kidney monitoring.
Symptoms
Glycogen storage disease type Ic often shows up in infancy or childhood as trouble keeping blood sugar steady between feeds, along with changes in growth and liver size. Many living with glycogen storage disease type Ic have a rounded or swollen-looking belly and may seem shaky, pale, or very tired if meals are delayed. The changes are often subtle at first, blending into daily life until they become more noticeable. The early features of glycogen storage disease type Ic can overlap with other glycogen storage disorders, so lab tests and genetic testing are usually needed to tell them apart.
Longer gaps between feeds or meals can trigger shakiness, sweating, paleness, irritability, or unusual sleepiness. In babies, this may look like poor feeding, limpness, or trouble waking for a feed. If blood sugar drops very low, seizures can happen.
The liver often becomes enlarged, which can make the belly look full, rounded, or firm. Waistbands may feel tight even while the arms and legs stay relatively slim. A healthcare professional may feel the liver below the ribs during an exam.
Many children grow more slowly than expected and may be shorter than their peers. Weight can collect around the middle while muscle bulk stays low. Puberty may also be delayed in some.
Because stored sugar cannot be released normally, energy can dip between meals or overnight. Some children seem weak, less active, or harder to settle first thing in the morning. Illness or poor intake can make these spells more noticeable.
How people usually first notice Glycogen storage disease ic?
The first signs of Glycogen storage disease IC are usually noticed in infancy, often when a baby goes too long without feeding and develops low blood sugar, which can cause shakiness, unusual sleepiness, irritability, or even seizures. Families or doctors may also notice a swollen belly from an enlarged liver, poor growth, feeding problems, or repeated episodes of vomiting and tiredness, especially between feeds or during illness. Because Glycogen storage disease IC is rare and symptoms can overlap with other conditions, it is often first recognized when these early problems keep happening and blood tests show a pattern suggesting the body cannot release stored sugar normally.
Types of Glycogen storage disease ic
Glycogen storage disease IC is a very rare inherited form within the glycogen storage disease type I group. Unlike some genetic conditions, no separate, widely accepted variants of glycogen storage disease IC are recognized today. In practice, experts usually discuss it as a single clinical entity, although symptom severity can still vary from one person to another.
No distinct types
No distinct types of glycogen storage disease IC are widely recognized. People living with glycogen storage disease IC may still have differences in symptoms and severity, but these are not considered separate disease variants.
Can I slow down the onset of symptoms?
For glycogen storage disease type IC, there is no good evidence that lifestyle changes can meaningfully delay the first symptoms, because this is an inherited condition that usually starts in infancy or early childhood. Once someone is living with it, early diagnosis and specialist care with a carefully planned eating schedule can help reduce low blood sugar and other complications, but that is not the same as preventing the condition from starting. Research is ongoing, and while good day-to-day care may lower the risk of some problems, it cannot guarantee that symptoms will be delayed or avoided.
What genetics can tell you about symptoms
In glycogen storage disease type I, genetics can help explain the general symptom pattern because different gene changes can affect how strongly the body struggles to keep blood sugar steady and process glycogen. This can influence which problems are more noticeable, such as low blood sugar, an enlarged liver, growth delay, or repeated infections in some subtypes, and it may also affect how early symptoms begin and how severe they become. Even so, genetics does not predict everything, and many living with the same subtype can still have milder or more severe symptoms than others.
Causes and risk factors
Glycogen storage disease type Ic is caused by inherited changes in the glucose-6-phosphate transport system, which blocks a key step in releasing stored sugar. It usually runs in families in an autosomal recessive pattern, so a child is affected only if both parents pass on the changed gene. Family history and having two carrier parents are the main risk factors for glycogen storage disease type Ic. Lifestyle and environment do not cause it, but fasting, missed meals, and illness can make early symptoms of glycogen storage disease type Ic more likely, especially in young children. Genetic testing can sometimes clarify your personal risk.
What are the most common causes or risk factors?
Glycogen storage disease type I(c) is usually caused by inherited gene changes that stop the body from properly releasing sugar from stored glycogen, especially in the liver. The main risk factors are having a family history of the condition, having both parents who carry the changed gene without knowing it, and being born to parents who are blood relatives, which makes this kind of inherited condition more likely. There are no known lifestyle or diet-related causes.
Environmental and biological risk factors
When people ask about risk factors for glycogen storage disease Ic, the answer is usually more about family biology than about day-to-day exposures. Awareness of both biological and environmental influences helps you feel prepared. Glycogen storage disease Ic is most likely when a baby inherits the related change from both biological parents, and no clear outside exposure has been shown to cause it.
Glycogen storage disease Ic usually happens when both biological parents carry the same condition-related change, even though they are often healthy themselves. If both parents are carriers, the chance of having an affected child is higher.
A family history of glycogen storage disease Ic can suggest that the same condition-related change is present in close relatives. This matters most when a brother, sister, or previous child has been affected.
When biological parents are blood relatives, such as cousins, they are more likely to share the same rare condition-related change. That can increase the likelihood of glycogen storage disease Ic in a child.
Unlike some birth conditions, glycogen storage disease Ic has no well-established link to routine foods, infections, medicines, or everyday environmental exposures during pregnancy. For many families, this means it was not caused by something a parent did or did not do.
Genetic risk factors
For families dealing with glycogen storage disease ic, the main risk factors are inherited ones rather than anything a parent did or did not do. Some risk factors are inherited through our genes. This condition usually develops when a child is born with changes in both copies of a gene involved in releasing stored sugar, although older subtype names like glycogen storage disease ic have shifted as testing improved. When people ask about the genetic causes of glycogen storage disease ic, the biggest clues are carrier parents, family history, and parents who are biologically related.
Recessive inheritance: Glycogen storage disease ic is usually passed down in an autosomal recessive pattern, meaning a child inherits two nonworking gene copies, one from each parent. Parents often feel completely well because one working copy is usually enough to prevent the disease.
Carrier parents: If both parents carry the same gene change, each pregnancy has a 25% chance of producing a child with glycogen storage disease ic. Each pregnancy also has a 50% chance of producing a child who is a healthy carrier.
Family history: A known family history of glycogen storage disease ic or a similar glycogen storage disorder raises the chance that the same gene change is being passed through the family. Even strong risks don’t guarantee a specific outcome, but they often lead doctors to suggest carrier or family testing.
Affected sibling: If one child in the family has glycogen storage disease ic, brothers and sisters can also be affected or be healthy carriers. This pattern is often what first alerts families that the condition is inherited.
Related parents: Parents who are biologically related, such as cousins, are more likely to carry the same rare gene change. That increases the chance of a recessive condition like glycogen storage disease ic in their children.
Older subtype label: The name glycogen storage disease ic comes from an older way of grouping type I glycogen storage disorders based on where sugar handling breaks down inside cells. Because the labeling has changed over time, modern genetic testing may be needed to confirm the exact gene involved.
Lifestyle risk factors
Glycogen storage disease IC is an inherited metabolic disorder, so lifestyle habits do not cause it. However, how lifestyle affects glycogen storage disease IC can be very important for preventing low blood sugar, reducing metabolic stress, and lowering the risk of complications. Daily routines around meals, fasting, activity, hydration, and illness management often have direct effects on symptoms and safety.
Long gaps without food can trigger hypoglycemia because people with glycogen storage disease IC cannot maintain normal blood glucose well during fasting. Regular meals, planned snacks, and prescribed overnight feeding strategies can help prevent dangerous drops in blood sugar.
Skipping prescribed carbohydrates or using an unbalanced eating pattern can worsen hypoglycemia and increase lactic acidosis, ketosis, or fatigue. Following the metabolic team's plan for complex carbohydrates, including uncooked cornstarch when prescribed, helps provide a steadier glucose supply.
Excess fructose and galactose can worsen the metabolic imbalance in glycogen storage disease IC because these sugars feed into pathways the body cannot handle normally. Careful restriction of foods and drinks high in these sugars may reduce biochemical abnormalities and long-term liver stress.
Strenuous or prolonged exercise can increase glucose use and raise the risk of hypoglycemia, muscle symptoms, or metabolic decompensation if fuel intake is not adjusted. Gentle to moderate activity is often better tolerated when paired with individualized pre-exercise nutrition guidance.
Risk prevention
Because glycogen storage disease IC is an inherited condition, there is usually no way to prevent the disease itself after a baby is conceived. For most families, prevention in glycogen storage disease IC means lowering the risk of low blood sugar, liver problems, poor growth, and other complications through steady daily care. If glycogen storage disease IC runs in your family, genetic counseling can help clarify future pregnancy risks and testing options. Different people need different prevention strategies—there’s no single formula.
If glycogen storage disease IC is known or suspected in a family, genetic counseling can help parents understand recurrence risk before pregnancy. Carrier testing and reproductive options may help some families reduce the chance of having another affected child.
In glycogen storage disease IC, long gaps without food can trigger low blood sugar and stress on the liver. Planned meals, overnight feeding strategies, or uncooked cornstarch when prescribed can help keep glucose levels steadier.
Illness, vomiting, or poor intake can quickly make glycogen storage disease IC harder to manage. A written sick-day plan with emergency glucose guidance and clear rules for when to seek urgent care can help prevent severe drops in blood sugar.
Regular follow-up with a metabolic specialist helps catch problems early, before they become more serious. Blood tests, growth checks, and liver monitoring are part of prevention too.
Can you prevent Glycogen storage disease ic?
No, glycogen storage disease type IC usually cannot be prevented because it is an inherited condition that someone is born with, not something caused by diet, exercise, or everyday habits. If it runs in your family, genetic counseling and family testing may help you understand the chance of passing it on and talk through testing options before or during pregnancy. Early diagnosis cannot stop the condition from happening, but it can help people living with it get care sooner and lower the risk of complications.
Transmission
Glycogen storage disease Ic is not infectious, so it cannot spread from person to person through coughing, kissing, sex, blood, food, or everyday contact. Instead, how Glycogen storage disease Ic is inherited is the key issue: it is usually passed down in an autosomal recessive pattern, meaning a child must inherit one nonworking gene copy from each parent.
Many parents are healthy carriers and have no symptoms, so they may not know they carry the gene change. If both parents are carriers, each pregnancy has a 25% chance of Glycogen storage disease Ic, a 50% chance that the child will be a carrier, and a 25% chance that the child will inherit neither changed copy.
When to test your genes
Consider genetic testing if you or your child has unexplained low blood sugar, enlarged liver, poor growth, high lactate or triglycerides, or a family history of glycogen storage disease. Testing can confirm GSD type Ic, guide diet and fasting plans, and help relatives understand their own carrier or affected status.
Diagnosis
Glycogen storage disease type IC is usually diagnosed when a baby or child has a pattern of low blood sugar, an enlarged liver, and poor growth or feeding problems that prompt further testing. Because this condition is rare and can look like other metabolic disorders, doctors often combine exam findings, lab results, and genetic tests to make the diagnosis of glycogen storage disease type IC. Getting a diagnosis is often a turning point toward answers and support.
Doctors look at the overall pattern of symptoms, such as episodes of low blood sugar between feeds, a swollen belly from an enlarged liver, and slow growth. They also ask when symptoms began and whether infections, mouth sores, or bowel problems have been part of the picture, since related forms can overlap.
Blood tests can show low glucose, high lactate, high uric acid, and high blood fats, especially during fasting. These findings do not prove glycogen storage disease type IC on their own, but they strongly suggest a glycogen storage disease and help rule out other causes.
An exam and imaging findings such as liver ultrasound may show an enlarged liver caused by stored glycogen and fat. This helps support the diagnosis and can also check for complications over time.
Genetic testing is the main way to confirm the genetic diagnosis of glycogen storage disease type IC. Your provider may suggest a gene panel for glycogen storage diseases because several conditions can cause very similar symptoms.
How is Glycogen storage disease ic diagnosed?
Doctors usually diagnose glycogen storage disease Ic by putting together the pattern of symptoms, a physical exam that may show an enlarged liver, and blood and urine tests showing that the body is having trouble keeping blood sugar steady. Genetic testing can help confirm that it is a glycogen storage disease and may help identify the exact type, but if the answer is still unclear, doctors may use a small liver sample or other special lab tests. Because this condition is rare, diagnosis is often made or confirmed by a doctor who specializes in rare inherited conditions.
Stages of Glycogen storage disease ic
Glycogen storage disease ic does not have defined progression stages. This condition is usually present from infancy or childhood and does not follow a standard step-by-step pattern of worsening that doctors divide into stages. Instead, symptoms can vary from one person to another, and care focuses on tracking problems such as low blood sugar, growth concerns, liver enlargement, and blood test changes over time; the early symptoms of glycogen storage disease ic often prompt this first evaluation. Doctors usually start with a conversation about symptoms and feeding patterns, then use blood tests, urine tests, imaging, and sometimes genetic testing to confirm the diagnosis and monitor health over time.
Outlook and prognosis
With early diagnosis and careful lifelong treatment, many people with glycogen storage disease Ic can survive into adulthood and maintain a good quality of life, although strict dietary management and regular specialist follow-up are usually needed. Prognosis depends largely on how well low blood sugar and metabolic abnormalities are controlled, because poor control increases the risk of growth delay, delayed puberty, kidney disease, bone problems, gout, and liver complications such as adenomas. Some individuals may also develop serious infections or inflammatory bowel symptoms if their disease behaves like the neutropenia-associated forms of glycogen storage disease type I. Mortality is much lower than in the past because of uncooked cornstarch therapy, nutritional support, and better monitoring, but life-threatening complications can still occur from severe hypoglycemia, sepsis, progressive kidney disease, or rarely malignant transformation of liver tumors. Long-term outcome is generally best in people who receive consistent metabolic care from childhood and are monitored closely for liver, kidney, blood, and growth-related complications.
Long-term effects
For many living with glycogen storage disease Ic, the long-term picture centers on keeping blood sugar steady and limiting strain on the liver, kidneys, bones, and growth. Long-term effects vary widely, and severity can differ from one person to another. Over time, daily routines may need to account for repeated low blood sugar and other metabolic changes that can affect school, work, sleep, and energy. Early symptoms of glycogen storage disease Ic can start in infancy or childhood, but some long-term effects become clearer over years of follow-up.
Recurrent low blood sugar can remain a major long-term feature of glycogen storage disease Ic. Over years, this can affect daily functioning, concentration, stamina, and safety, especially during illness or long gaps without food.
Many people with glycogen storage disease Ic continue to have an enlarged liver, and some develop benign liver growths called adenomas over time. These changes need long-term monitoring because, in a small number of people, liver complications can become more serious.
Kidney strain can build gradually and may lead to protein leaking into the urine, high blood pressure, or reduced kidney function. In adulthood, some people with glycogen storage disease Ic develop chronic kidney disease.
In childhood, slow growth and delayed puberty can occur if the condition is hard to control. Adult height may be below expected for some, although outcomes vary.
How is it to live with Glycogen storage disease ic?
For many living with glycogen storage disease type Ic, daily life revolves around avoiding fasting, with carefully timed meals, overnight feeding plans, or uncooked cornstarch to keep blood sugar steady, along with regular medical follow-up for liver, kidney, and blood chemistry issues. Some may also face repeated infections or mouth sores, which can make school, work, and social plans less predictable. This often affects the whole household, because parents, partners, teachers, and other caregivers may need to help with meal timing, watch for warning signs of low blood sugar, and keep emergency supplies close by.
Treatment and drugs
Treatment for glycogen storage disease IC focuses on keeping blood sugar steady and preventing the body from slipping into fasting, which can trigger low blood sugar and other problems. For many people, treatment begins with small daily steps, such as frequent meals, carefully timed snacks, and uncooked cornstarch or overnight tube feeding to provide a slow, steady source of glucose. Doctors also treat complications of glycogen storage disease IC, and some may need medicines to lower uric acid, protect the kidneys, or help manage high fats in the blood. In infants and children, care is usually guided by a metabolic specialist and dietitian, because the safest plan can change with age, growth, illness, and activity. If you are looking into the early treatment options for glycogen storage disease IC, it helps to know that close follow-up and a personalized eating plan are the mainstay, while medicines are added based on specific symptoms and test results.
Can you cure Glycogen storage disease ic?
No, there is no cure for glycogen storage disease IC at this time. Treatment can still help a lot by keeping blood sugar steady and lowering the risk of problems with the liver, kidneys, and growth, often through a carefully planned diet, regular meals, and sometimes medicines. Many people living with this condition do best with ongoing care from a specialist team.
Non-drug treatment
For many living with glycogen storage disease type Ic, day-to-day care centers on keeping blood sugar steady and preventing long gaps without food. Treatment often begins not at the pharmacy, but with carefully timed meals, special starch plans, and close nutrition support. Because this condition can affect the liver, growth, energy, and tolerance for fasting, non-drug care is usually tailored with a metabolic specialist and dietitian. Not every approach works the same way, so plans are adjusted as children grow and routines change.
Regular meals and snacks help prevent low blood sugar between feeds. This is one of the main ways to reduce shakiness, sweating, irritability, and other early symptoms of glycogen storage disease type Ic. Long fasting periods are usually avoided, including overnight.
Uncooked cornstarch is often used as a slow-release source of glucose. Many people with glycogen storage disease type Ic take it on a schedule to help keep blood sugar stable between meals, especially at night or between longer gaps in eating.
Some children need overnight tube feeds or other planned nighttime nutrition when fasting is not safe. This can help protect sleep while also lowering the risk of overnight low blood sugar.
A specialist dietitian can help build a meal plan with the right balance of carbohydrate, protein, and overall calories for growth. Supportive therapies can also make eating plans more practical for school, travel, sports, and family routines.
Your genes may have an impact on how drugs work for you
For people living with glycogen storage disease type Ic, treatment usually centers more on careful eating plans than on medicines, so there are no widely used drug choices where a person’s inherited changes are known to clearly guide treatment. Even so, the condition can affect the liver and sometimes the kidneys, and that can change how the body breaks down or clears some medicines, which may raise the chance of side effects or mean doses need to be adjusted. In day-to-day life, this means doctors often choose medicines carefully and may keep a closer eye on response and safety, especially if there are liver, kidney, or blood-fat problems.
Pharmacological treatments
For many living with glycogen storage disease Ic, treatment is centered more on food planning than on medicines, because no drug fixes the underlying enzyme problem. When medications are used, they usually treat complications such as high uric acid, kidney strain, or very high blood fats. Some medicines work quickly, while others are used longer term to help protect organs and lower risk over time. Because this condition is rare, drug choices are usually tailored by a metabolic specialist.
Allopurinol is often used when glycogen storage disease Ic causes high uric acid levels or gout. It helps lower uric acid and may reduce joint pain, swelling, and kidney stone risk.
Fibrates such as fenofibrate or gemfibrozil, and sometimes statins, may be used if blood fats stay very high despite diet treatment. In some people with glycogen storage disease Ic, this can help lower the risk of pancreatitis and may improve abnormal cholesterol patterns.
Medicines such as enalapril or lisinopril may be prescribed if there is protein leaking into the urine or other early signs of kidney stress. They do not treat the root cause of glycogen storage disease Ic, but they can help protect kidney function over time.
Losartan or similar angiotensin receptor blockers may be used when kidney protection is needed and an ACE inhibitor is not a good fit. Not everyone responds to the same medication in the same way, so dose and drug choice depend on blood pressure, lab results, and side effects.
Genetic influences
For families dealing with frequent feeds and the risk of low blood sugar in glycogen storage disease Ic, it can help to know that this is an inherited form of the condition. Glycogen storage disease Ic is caused by changes in SLC37A4, a gene that helps move certain sugar-related substances inside cells so the body can release stored sugar normally. It follows an autosomal recessive pattern, so a child needs to inherit two changed copies of the gene, one from each parent, to develop glycogen storage disease Ic. A carrier means you hold the gene change but may not show symptoms. If both parents are carriers, each pregnancy has a 1 in 4, or 25%, chance of glycogen storage disease Ic, which is why genetic testing and counseling can help clarify risk for siblings and future children.
Is Glycogen storage disease ic genetic?
Genetics are central to Glycogen storage disease IC, which is caused by inherited changes in a gene involved in breaking down glycogen. The exact variant can help confirm the diagnosis, guide family testing, and sometimes explain differences in severity.
Having a genetic risk is not necessarily a diagnosis
Genetic variants are a normal, common part of human biology. Most do not directly affect health and simply reflect natural differences among people. In many genes, carrying a variant associated with a condition suggests a possible link rather than a certain diagnosis, especially when several genes and environmental factors are involved. In some cases, though, a single well-understood variant in a particular gene is enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
For many living with glycogen storage disease type IC, treatment is not one-size-fits-all: the exact gene change can help doctors predict which problems need the closest follow-up. Because glycogen storage disease type IC is now usually grouped with a closely related form of glycogen storage disease type I, genetic testing is often used to confirm the diagnosis and look for risks such as low white blood cells, frequent infections, or gut inflammation. Variants in certain genes may raise the chance of these complications, which can change whether care focuses mainly on diet treatment, such as frequent meals and uncooked cornstarch, or whether medicines that support white blood cells are also considered. In glycogen storage disease type IC, genetics usually matters less for how the body breaks down a drug and more for deciding which treatments are needed in the first place. If families are wondering how genes affect treatment for glycogen storage disease type IC, the main benefit of testing is that it helps tailor care around low blood sugar, liver health, growth, and infection risk. Doctors still adjust treatment over time based on symptoms, lab results, age, and how someone is doing day to day.
Interactions with other conditions
Illnesses that upset eating and drinking, such as stomach bugs or the flu, can make glycogen storage disease IC harder to manage because fasting, vomiting, and dehydration may bring on low blood sugar and a buildup of lactic acid more quickly. If liver or kidney problems are also present, some medicines may need extra caution, and routine blood tests often become more important. Doctors call it a comorbidity when two conditions occur together, and in glycogen storage disease IC this can matter because one problem may change how the other is treated. For many, this can mean that the early symptoms of glycogen storage disease IC become more noticeable during another illness, such as unusual tiredness, shakiness, belly discomfort, or trouble keeping blood sugar steady. People with glycogen storage disease IC may also need closer follow-up if they develop high uric acid, high blood fats, or liver growths, since these can raise the risk of related problems like gout, pancreatitis, or ongoing liver disease. Because the pattern can vary from one person to another, it is worth asking your care team how any new diagnosis, infection, or medication could affect day-to-day management.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Glycogen storage disease ic?
Other glycogen storage diseases, especially types Ia and Ib, can look very similar because they can also cause low blood sugar, an enlarged liver, slow growth, and high fat levels in the blood. Doctors may also consider other inherited problems with how the body handles sugar, such as galactosemia or hereditary fructose intolerance, as well as some rare conditions that make it hard to use stored fat for energy. In babies and children, a few hormone problems can also cause repeated low blood sugar and poor growth, so these may need to be ruled out too.
History
Long before modern lab testing, doctors recognized that some children developed an unusually enlarged liver, low blood sugar, and poor growth, often with a pattern of symptoms that became most obvious between meals or overnight. For families, this could mean a baby or young child who seemed sweaty, shaky, pale, or unusually tired if feeding was delayed. These early descriptions gradually led physicians to group certain cases together under what is now called glycogen storage disease type I, including glycogen storage disease type Ic.
In 1929, the German pathologist Edgar von Gierke gave one of the first clear medical descriptions of this group of conditions after studying children with a very enlarged liver and problems handling stored sugar. As medical science evolved, doctors began to notice that not all children with glycogen storage disease type I looked exactly the same in the clinic or on specialized testing. Over time, glycogen storage disease type Ic was used as a subtype label for people whose test results suggested a particular problem in the pathway that moves and releases stored glucose.
Later research showed that some of the older subtype labels did not reflect truly separate diseases in the way doctors first thought. Medical classifications changed as scientists learned more about the underlying biology, and glycogen storage disease type Ic is now largely considered part of the broader glycogen storage disease type I spectrum rather than a clearly separate condition in everyday clinical use. That shift matters because older papers, case reports, or family records may still use the name glycogen storage disease type Ic, while newer sources may group the same features differently.
In recent decades, awareness has grown that historical names can affect how people find information, especially when searching for the early symptoms of glycogen storage disease type Ic or reading older medical records. Knowing this history can make the condition less confusing: the name has changed over time, but the core medical concern has remained the same, namely the body’s difficulty keeping blood sugar steady and managing stored glycogen in a healthy way. Today, the history of glycogen storage disease type Ic is mainly a story of improving classification, better testing, and clearer understanding of where this older label fits within a wider group of related conditions.